BactiQuant A/S

BactiQuant A/S

CCPH:BACTIQ
2.42
DKK
+0.09
(+3.86%)
93.80MMarket Cap
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.25
0.26
0.25
0.39
0.59
0.53
0.27
0.28
- -
Basic EPS, GAAP
-0.05
-0.01
-0.04
-0.64
-0.68
-0.57
-0.52
-0.46
- -
Free Cash Flow per Basic Share
- -
-0.09
- -
-0.72
-0.85
-0.38
-0.49
-0.35
- -
Dividend per Share
- -
- -
0.07
- -
- -
- -
- -
- -
- -
Book Value per Share
0.55
0.5
0.41
0.96
0.62
0.55
0.03
0.46
0.33
Tangible Book Value per Share
0.13
0.08
0.12
0.68
0.35
0.33
-0.15
0.36
0.25
Basic Weighted Avg Shares
22
22
22
21
21
23
26
30
34
Sales/Revenue/Turnover
5
6
5
8
12
12
7
8
- -
Operating Margin (%)
-0.03
-6.84
-23.48
-151.68
-110.4
-88.62
-176.21
-150.24
- -
Depreciation Expense
- -
- -
1
- -
2
1
2
2
- -
Net Income, GAAP
-1
- -
-1
-14
-14
-13
-14
-14
- -
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-21.46
-4.83
-17.91
-162.12
-114.5
-106.51
-191.25
-166.29
- -
Working Capital
5
4
3
13
11
15
3
20
15
LT Debt
- -
- -
- -
1
5
8
8
7
6
Total Equity
12
11
9
21
14
14
1
17
12
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
-2.39
-9.92
-90.26
-80.21
-91.26
-181.74
-154.13
- -

Capital Structure

DKK

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
ST Debt
2
2
2
LT Borrowings
8
7
6
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
29
38
38
Market Capitalization
77
124
94

Working Capital

DKK

•

in mil. unless spec.
Jun'25
Dec'25
Jun'26
Total Current Assets
13
24
18
Cash, Cash Equivalents & STI
8
18
12
Accounts Receivable, Net
1
1
1
Inventories
4
4
5
Total Current Liabilities
3
4
4
Payables & Accruals
- -
- -
- -
ST Debt
2
2
2
Deferred Revenue
- -
- -
- -

Growth Rates

DKK

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
482.53%
2,404.32%
Free Cash Flow
- -
4,278.45%
-18.96%
Net Income, GAAP
- -
256.61%
0.81%
Sales/Revenue/Turnover
- -
14.85%
15.94%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
7
2025
- -
- -
8
2026
- -
- -
- -

Semi-annual Earnings Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.52
2025
- -
- -
-0.46
2026
- -
- -
- -

Semi-annual Dividends Per Share

DKK

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -

Company Description

CEO
Morten Miller
Full Time Employees
12
Sector
Electronic technology
Industry
Aerospace & defense
Address
Blokken 75 Birkerod CR Denmark 3460
IPO Date
Feb 5, 2021
Business
BactiQuant A/S develops and provides advanced technology solutions for the monitoring and quantification of bacterial contamination levels in various water systems. Its core product portfolio includes the BactiQuant Mobile Lab, a handheld tool designed for rapid, on-site bacterial pollution tracking, and BactiQuant Online, a digital platform enabling continuous, real-time surveillance and automation in water management. These technologies apply to a wide range of water types including industrial wastewater, potable water, saline water, and purified water primarily used in pharmaceutical production. BactiQuant serves diverse industry segments such as aquaculture, public water utilities, data centers, oil and gas, pharmaceuticals, and general industrial wastewater treatment. Founded in 1999 and headquartered in Horsholm, Denmark, the company operates globally across five continents. In terms of recent developments, BactiQuant has emphasized strategic partnerships and market expansion, aiming to enhance its global presence and leverage scalable production systems for significant growth. The company has continued to innovate its product offerings by advancing the digitization and automation capabilities of its BactiQuant Online platform to improve efficiency and reliability in water system management. This includes quick deployment and integration into various industrial water networks for optimized bacterial monitoring. BactiQuant's technology is recognized for its high sensitivity fluorescence-based analysis validated by peer-reviewed studies and regulatory bodies like the US-EPA. The company remains committed to sustainability goals aligned with multiple UN Sustainable Development Goals, reinforcing its role in smarter, more sustainable water management worldwide. BactiQuant's business model is based on business-to-business sales of its technology and related chemistry test consumables necessary for ongoing bacterial measurement. Overall, BactiQuant A/S stands as a specialized provider of bacterial contamination monitoring solutions within the water treatment industry, offering both mobile and online product lines backed by technical innovation and expanding strategic collaborations. This description incorporates the company's product details, market sectors, geographic scope, founding information, and latest strategic and operational changes as of 2025.